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Determinants of inﬂuenza vaccination among solid organ transplant recipients
attending Sicilian reference center
Vincenzo Restivoa, Giovanni Vizzinib, Alessandra Mularonib, Cinzia Di Benedettob, Santi Mauro Gioeb,
and Francesco Vitalea
aDepartment of Science for Health Promotion and Mother-Child Care “G. D’Alessandro,” University of Palermo, Palermo, Italy; bIRCCS-ISMETT, Palermo,
Italy
ABSTRACT
Among solid organ transplant recipients, inﬂuenza infection is commonly associated with higher morbidity
and mortality than immunocompetent hosts. Therefore, in these subjects inﬂuenza vaccination is of
paramount importance. The main objective of the study was to assess compliance to vaccination and
analyze factors associated with inﬂuenza vaccination of solid organ transplant recipients admitted to the
Sicilian solid organ transplant Reference Center IRCCS-ISMETT in Palermo during 2014–2015 inﬂuenza
season. Thirty one (37.8%) out of 82 solid organ transplant recipients were vaccinated against inﬂuenza.
The main reason for vaccination refusal was fear of adverse reaction (n D 16, 31.4%), impaired health
status (n D 14, 27.4%) and low vaccine efﬁcacy (n D 10, 19.6%). Vaccinated solid organ transplant
recipients compare with unvaccinated had smaller hospital admissions for infectious respiratory diseases
(9.7% Vs 23.5%) during surveillance period. On multivariate analysis the factors positively associated with
inﬂuenza vaccination were the advice of Reference Center physicians (OR 53.4, p < 0.001) and to perform
vaccine against pneumococcus (OR 7.0, p D 0.016). This study showed that Reference Center physicians
play a key role on vaccine communication and recommendation for patients at risk and it underlines the
effectiveness of inﬂuenza vaccination in solid organ transplant recipients. However, it remains that,
although physician advice resulted a strong determinant for vaccination, inﬂuenza vaccination coverage
in this subset of population remains still unsatisfactory.
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Introduction
Inﬂuenza is a considerable public health issue due to its dissem-
ination and contagiousness, causing annually 3 to 5 million
cases of severe illness and 1 million deaths worldwide.1 This
disease is more serious in hospital setting, where healthcare
workers are at increased risk of inﬂuenza, both for exposure to
infected patients and viruses present outdoor.2 Indeed, inﬂu-
enza attack rate varies between 5–10% in general population
whereas 11–59% in healthcare workers who take care of
patients with ILI.3 Because inﬂuenza is more severe among
patients with chronic diseases National Health Authorities
identiﬁed at risk groups, including SOT recipients, to which
recommend anti-inﬂuenza and anti-pneumococcal vaccina-
tion.4,5,6,7 In particular IDSA guidelines counselled to adminis-
ter inactivated inﬂuenza vaccine since one month after
transplantation during community inﬂuenza outbreak.8 Indeed
inﬂuenza is even more common among SOT recipient as
showed in a 10-year longitudinal study with an incidence of 4.3
cases per 1,000 person years.9 In addition to complications
(pneumonia and low airways infections) of general population,
inﬂuenza can cause transplant rejection in SOT recipients.9
Despite wide dissemination of guidelines among healthcare
workers, vaccination against inﬂuenza is not yet standard
practice in transplant centers. According to Dinits-Pensy
et al.10 many nephrological practices are reluctant to administer
vaccines, partly due to a lack of understanding regarding their
risk/beneﬁt ratio. Slightly different results were found among
heart transplant centers. Of the 28 transplant centers investi-
gated in a multicenter study by White-Williams et al.11 25 rec-
ommended inﬂuenza vaccination. The remaining 3 centers did
not recommend inﬂuenza vaccination because of a supposed
association with allograft rejection. Furthermore, little is known
about predictors of vaccine uptake in SOT recipients. With the
exception of Berben et al.12 that founded positive vaccination
status signiﬁcantly related to older age in a population of kid-
ney transplant recipients.
The main objective of study was to analyze vaccination
uptake and its determinants among SOT recipients to imple-
ment immunization adherence in a population at higher risk of
inﬂuenza complications.
Result
A total of 82 SOT recipients were enrolled during the study
period. Table 1 shows demographic and clinical characteristics
of patients. Overall, the mean age was 50 y (CI 47–52),
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employed were more represented (48.8%) followed by retired
from work (37.8%) and males were more recurring than
females (73.2% Vs. 26.8%). Only 31 out of 82 (37.8%) per-
formed vaccination against-inﬂuenza. More than half of SOT
recipients (57.3%) declared to have not suffered from ILI dur-
ing 3 previous inﬂuenza seasons. Moreover seventeen patients
(20.7%) received anti-pneumococcal vaccination. The most fre-
quently graft performed was liver (41.5%) followed by lung
(26.8%) and kidney (18.3%). SOT recipients resulted suffering
more from cardiovascular diseases (73.2%) followed by chronic
hepatitis (37.8%) and chronic renal failure (30.5%).
Those who performed anti-inﬂuenza vaccination were older
(53.6 Vs 47.5 years, respectively; p D 0.063), and more fre-
quently retired from work than non-vaccinated ones (58.1% Vs
41.9%). On the other hand unvaccinated SOT patients were
more recurrent than vaccinated employed (80.0% Vs. 20%) and
unemployed (54.5% Vs 45.5%; p D 0.004). Furthermore, who
suffered from ILI during the 3 previous seasons investigated,
were signiﬁcantly more resistant to anti-inﬂuenza vaccination
(77.2% Vs 22.8%; p D 0.016). Comparing vaccinated with
unvaccinated SOT recipients the main source of information in
support of vaccination was RC physician (84.2% Vs. 15.8%),
whereas General Practitioner (41.4% Vs. 58.6%) and other
physician (20% Vs. 80%) resulted less effective
(p D 0.022). The type of graft and medical history did not seem
to inﬂuence the choice to be vaccinated against inﬂuenza
among SOT recipients.
All factors signiﬁcantly associated with anti-inﬂuenza vacci-
nation adherence on bivariate analysis were included in a mul-
tivariate logistic analysis (Table 2). Supporting anti-inﬂuenza
vaccination by RC physician (OR of 53.4; p < 0.001), followed
by have been previously vaccinated against pneumococcus (OR
7.0; p D 0.016) were the main positively determinants of inﬂu-
enza vaccination among SOT recipients.
Table 1. Demographics and clinical characteristics of SOT recipients attending RC during 2014–2015 inﬂuenza season.
Total N
Vaccinated against
inﬂuenza (n D 31),
Unvaccinated against
inﬂuenza (n D 51),
(%-IQR) N (%-IQR) N (%-IQR) p
Sex Male 60 (73.2) 26 (43.3) 34 (56.7) 0.088
Female 22 (26.8) 5 (22.7) 17 (77.3)
Age 49.8 (46.6–52.0) 53.6 (48.6–50.5) 47.5 (43.4–51.6) 0.063
Country of origin Italian 79 (96.3) 31 (39.2) 48 (70.8) 0.169
Other 3 (3.7) 0 (0) 3 (100)
School level Nothing 3 (3.7) 2 (66.4) 1 (33.3) 0.128
Primary 23 (28.0) 11 (47.8) 12 (52.2)
Secondary 27 (32.9) 12 (44.4) 15 (55.6)
College 19 (23.2) 3 (15.8) 16 (84.2)
University 10 (12.2) 3 (30.0) 7 (70.0)
Employment status Employed 40 (48.8) 8 (20.0) 32 (80.0) 0.004
Retired 31 (37.8) 18 (58.1) 13 (41.9)
Unemployed 11 (13.4) 5 (45.5) 6 (54.5)
Smoking habits Never 43 (52.4) 12 (27.9) 31 (71.1) 0.132
Not for 10 y 16 (19.6) 7 (43.7) 9 (56.3)
Yes 23 (28.0) 12 (52.2) 11 (47.8)
ILI for 3 last seasons Yes 35 (42.7) 8 (22.8) 27 (77.2) 0.016
Source of information about
inﬂuenza vaccination
General Practitioner 29 (35.4) 12 (41.4) 17 (58.6) 0.022
Reference center physician 19 (23.2) 16 (84.2) 3 (15.8)
Parents/friends 4 (4.9) 2 (50.0) 2 (50.0)
Other physician 5 (6.1) 1 (20.0) 4 (80.0)
Vaccination against pneumococcus Yes 17 (20.7) 11 (64.7) 6 (35.3) 0.010
Performed transplant Liver 34 (41.5) 13 (38.2) 21 (61.8) 0.653
Heart 9 (11.0) 4 (44.4) 5 (55.6)
Heart and kidney 1 (1.2) 0 (0) 1 (100)
Lung 22 (26.8) 9 (40.9) 13 (59.1)
Kidney 15 (18.3) 4 (26.7) 11 (73.3)
Liver and kidney 1 (1.2) 1 (100) 0 (0)
Medical history Bronchopulmunary diseases 26 (31.7) 13 (50.0) 13 (50.0) 0.121
Cardiovascular diseases 60 (73.2) 24 (40.0) 36 (60.0) 0.498
Diabetes 25 (30.5) 10 (40.0) 15 (60.0) 0.786
Chronical renal failure 25 (30.5) 8 (32.0) 17 (68.0) 0.473
Immunosuppressive diseases 1 (1.2) 0 (0) 1 (100) 0.433
Chronic hepatitis 31 (37.8) 12 (38.7) 19 (61.3) 0.895
Leukemia/lymphoma 3 (3.7) 0 (0) 3 (100) 0.169
Solid tumor 9 (11.0) 4 (44.4) 5 (55.6) 0.663
Other diseases 51 (62.2) 18 (35.3) 33 (64.7) 0.548
Table 2. Multivariate analysis of factors associated with inﬂuenza vaccine uptake
among SOT recipients during 2014–2015 inﬂuenza season.
OR 95% CI
Sex (Male Vs. Female) 2.5 0.5 12.0
Age (per year increase) 1.0 0.9 1.1
Worker (Yes Vs. No) 0.4 0.1 2.5
Retired (Yes Vs. No) 1.3 0.1 11.8
ILI for 3 previous seasons (Yes Vs. No) 0.4 0.1 1.3
Vaccination against pneumococcus (Yes Vs. No) 7.0 1.4 34.4
Inﬂuenza vaccination information by Reference
Center physician (Yes Vs. No)
53.4 7.2 394.8
Inﬂuenza vaccination information by General
Practitioner (Yes Vs. No)
4.6 0.9 22.9
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Figure 1 shows the causes of missed inﬂuenza immunization
by SOT recipients. Among these, the fear of adverse reactions
(31.4%) followed by health status (27.4%) and low vaccine efﬁ-
cacy (19.6%) played a major role.
Figure 2 shows the effectiveness of inﬂuenza vaccination
analyzing the number of SOT recipients with at least one
admission for respiratory diseases in season 2014–2015. Those
who were not vaccinated had greater percentage of hospitaliza-
tions for respiratory disease compare with vaccinated (23.2%
Vs. 9.7%; p D 0.116).
Discussion
This study analyzes the determinants of anti-inﬂuenza vaccina-
tion in a major “at risk” category as SOT recipients. Vaccina-
tion coverage in 2014–2015 season, in Italy, showed a slight
decrease, with respect to previous season, both among general
population (13.6%) and at risk categories like over 65
(48.6%).13 In our series, observed values were lower in compari-
son with those reported by other studies conducted in SOT
recipients.14,15
Overall, the key determinant for anti-inﬂuenza vaccination
uptake was information provided by RC physician. According
to our data, the suggestion of RC physician weighted more than
General Practitioner, parents/friends and other sources. This
could be explained by the general persuasion about more spe-
ciﬁc awareness of specialists about vaccine recommendations in
this speciﬁc population.14 This result makes us reﬂect on the
need for continuous updating of physician especially those
treating critical subjects as also suggested by our group in a pre-
vious paper about up to date knowledge on inﬂuenza
epidemiology.16
Another factor positively associated with anti-inﬂuenza vac-
cination uptake among study population was to have had a pre-
vious experience of anti-pneumococcal vaccination (OR D 7.0;
p D 0.016). The ﬁnding that, in adult population, a favorable
opinion toward vaccination in general was associated with pre-
vious vaccination uptake of speciﬁc vaccines (inﬂuenza and
pneumococcal) is worthy of interest. Similarly, Nichol et al.17
also founded that positive attitudes toward immunization were
independently associated with both inﬂuenza and pneumococ-
cal vaccination behaviors among 700 immunocompromised
adult patients.
The main reason for vaccination failure is fear of adverse
events and in particular of graft rejection (data not shown in
table). Because successful vaccination requires a partial activa-
tion of the immune system, doubts have been raised about a
possible increase in the risk of acute rejection episodes, and
thus about the safety of inﬂuenza vaccination in transplant
patients.11 This fear, however, has not been substantiated by
scientiﬁc evidence.6 Indeed rate of rejections did not increase in
the months before, during, or after the administration of the
inﬂuenza vaccine.11 Another reason of missing vaccination was
impaired state of health similarly to other studies conducted in
Figure 1. Reasons for missed vaccination in SOT recipients.
Figure 2. Following hospitalizations for respiratory disease among SOT recipients with or without performing anti-inﬂuenza vaccine during 2014–2015 inﬂuenza season.
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the same area.18,19 Among SOT recipients this belief can be
attributed to the immunosuppressive therapy. Firstly it should
be stressed that, if immunosuppressive therapy could partially
decrease the immune system, it is true that to be exposed to
microorganisms in real life should be much more at risk in
respect of puriﬁed antigens contained in a vaccine. Subse-
quently, various studies have shown that SOT recipients anti-
body response to the inﬂuenza vaccine still signiﬁcantly
decreases the probability of contracting inﬂuenza.20,21
Monitoring SOT recipients admission to the Sicilian RC
during inﬂuenza season there were a higher probability of
health services request for respiratory diseases (pneumonia and
low airways infection) among unvaccinated than vaccinated
patients. This observation reveals an indirect proof of anti-
inﬂuenza vaccine effectiveness. Other studies have found health
beneﬁts of anti-inﬂuenza vaccine in high-risk categories.6,22
Even though further research is needed to evaluate the overall
risks and beneﬁts of anti-inﬂuenza-vaccine in SOT recipients.
Although the main limitation of study was the small sample
analysis, the low number of donor in the area under investiga-
tion makes relevant obtained results.23 Furthermore, the possi-
bility of a recall bias during administration of the questionnaire
may have been, although the use of electronic patient records,
to obtain information about SOT recipients health conditions,
should have reduced this risk.
In conclusion, this study underlines the need to improve the
patient-doctor relationship at a communication level, especially
in high risk patients concerning efﬁcacy and safety of vaccina-
tion. Therefore, sharing detailed scientiﬁc knowledge among
RC physician and General Practitioner will improve the aware-
ness about vaccination safety and efﬁcacy in general popula-
tion, ultimately promoting health among at risk population as
SOT recipients are.
Material and methods
This study was conducted with an observational design.
Patients were enrolled from 42nd week of 2014 to 16th week
of 2015 at IRCCS-ISMETT in Palermo (Sicilian SOT Refer-
ence Centre), an hospital with 78 beds for acute and 7 day
hospitals taking care of 5,000 patients and performing a mean
of 128 transplantation each year.24 All SOT recipients or
patients who performed a transplantation during hospital stay
were administered a structured interview. Variables included
in the questionnaire examined demographic characteristics
(sex, age, occupation), health (smoking habits, medical history,
type of graft) and vaccination status (anti-inﬂuenza and anti-
pneumococcal vaccines). To investigate the effectiveness of
anti-inﬂuenza vaccination it was registered patient with a hos-
pital admissions for respiratory diseases among SOT recipients
during all inﬂuenza season. This study was approved by the
Institutional Review Research Board IRCCS-ISMETT.
Statistical analysis
All data were analyzed using Stata v14.1 statistical software. For
all analyses, a p-value of 0.05 was assumed to indicate signiﬁ-
cance (2-tailed). Absolute and relative frequencies have been
reported for qualitative variables, and medians (IQR) have
been reported for quantitative, non-normally distributed varia-
bles. Normal distribution was veriﬁed by Shapiro Wilk’s test
for normality, and median data were compared using the Skew-
ness and Kurtosis test. Categorical variables were analyzed
using Chi square test (Mantel-Haenszel). All variables that
were found to be signiﬁcantly associated (p < 0.05) with inﬂu-
enza vaccination receipt in bivariate analysis were included in a
multivariable logistic regression model. Goodness of ﬁt was cal-
culated for each model, and the model with the lowest Akaike
Information Criterion was considered to have the best ﬁt.
Adjusted OR and CI 95% were calculated for the variables
retained in the ﬁnal model.
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